Leyvraz S. | Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
スポンサーリンク
概要
- LEYVRAZ S.の詳細を見る
- 同名の論文著者
- Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausannの論文著者
関連著者
-
Leyvraz S.
Pluridisciplinary Cancer Center Centre Hospitalier Universitaire Vaudois
-
Decosterd L.
Division Of Clinical Pharmacology Department Of Internal Medicine Bh 18-lab 218 Centre Hospitalier U
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Zaman K.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier U
-
Leyvraz S.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
ZANOLARI B.
Division de Pharmacologie clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
Zanolari B.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Zanolari B.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
-
Widmer N.
Division De Pharmacologie Clinique Laboratoire Bh 18-218 Department De Medicine Centre Hospitalier U
-
Buclin T.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Rochat B.
Plate-forme De Spectrometrie De Masse Department De Recherche Centre Hospitalier Universitaire Vaudo
-
Duchosal M.
Service D'hematologie Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Guignard N.
Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier U
-
Rochat B.
Quantitative Mass Spectrometry Facility Of The Chromatography-mass Spectrometry Platform Of The Univ
-
HAOUALA A.
Division de Pharmacologie clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
MONTEMURRO M.
Multidisciplinary Oncology Centre, Centre Hospitalier Universitaire Vaudois and University of Lausan
-
RIS H.
Divisions of Thoracic and Vascular Surgery, Centre Hospitalier Universitaire Vaudois and University
-
CRUCHON S.
Division of Clinical Pharmacology and Toxicology, University Hospital of Lausanne
-
Ris H.
Divisions Of Thoracic And Vascular Surgery Centre Hospitalier Universitaire Vaudois And University O
-
Haouala A.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
-
Montemurro M.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
DAHMANE E.
Division of Clinical Pharmacology and Toxicology, Department of Medicine, Lausanne, Centre Hospitali
-
MERCIER T.
Division of Clinical Pharmacology and Toxicology, Department of Medicine, Lausanne, Centre Hospitali
-
CSAJKA C.
Division of Clinical Pharmacology and Toxicology, Department of Medicine, Lausanne, Centre Hospitali
-
Cruchon S.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Csajka C.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Dahmane E.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Mercier T.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Widmer N.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
著作論文
- Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry
- An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma : First evidence of 4'-hydroxylated metabolites in breast cancer patients